Failure of Exogenous Insulin to Inhibit C-peptide Release from the Perfused Rat Pancreas
スポンサーリンク
概要
- 論文の詳細を見る
In order to ascertain whether insulin secretion is inhibited by insulin per se, the effect of exogenous rat insulin on basal and stimulatedrat C-peptide reactivity (CPR) release was studied in the isolated perfused rat pancreas. The pancreas was perfused with a medium containing 20 or 200ng/m<I>l</I> of rat insulinfor a 20 min equilibration period and successively for a 25 to 30 min test period during which time glucose (300mg/100m<I>l</I>), tolbutamide (500μg/m<I>l</I>), glucagon (500ng/m<I>l</I>) or arginine (10mm) was added as a secretagogue. The concentration of glucose in the basal medium was 60mg/100m<I>l</I>. Exogenous insulin did not significantly suppress the basal CPR secretion, nor did it cause a suppression of the peakvalue or incremental area of CPR while the pancreas was stimulated, but it rather augmented them. No inhibitory effect of exogenous insulin on the basal or stimulated CPR release was noticed in the present study.
- 社団法人 日本内分泌学会の論文
著者
-
TANAKA RYOICHI
The Second Department of internal Medicine, Osaka University Medical School
-
SHIMA KENJI
The Second Department of internal Medicine, Osaka University Medical School
-
SAWAZAKI NORIO
The Laboratory of Bioorganic Chemistry, Shizuoka College of Pharmacy
-
MATSUYAMA TATSUO
The Central Laboratory for Clinical Investigation, Osaka University Medical School
-
KUMAHARA YUICHI
The Second Department of internal Medicine, Osaka University Medical School
-
YANAIHARA NOBORU
The Department of Medicine and Geriatrics, Osaka University Medical School
関連論文
- Failure of Exogenous Insulin to Inhibit C-peptide Release from the Perfused Rat Pancreas
- Boiling Method for the Extraction of Gut Glucagon-like Immunoreactive Materials
- Failure of Somatostatin to Decrease Blood Glucose by Suppression of Extrapancreatic Glucagon in Severely Diabetic Depancreatized Dogs
- Comparison of the Changes in Plasma Human Growth Hormone (HGH) and Immuno-Reactive Glucagon (IRG) after Intravenous and Subcutaneous Injection of Glucagon